Latest Biotech Startup Funding Rounds

Robigo engineers biological crop-protection solutions that use targeted microbes to control plant pathogens while preserving beneficial organisms.

A regenerative-medicine company developing injectable microporous scaffolds that help the body rebuild tissue at damaged sites.

Eterna Regeneratives develops keratin-based biomaterials that guide mineral growth to repair enamel and, in a separate application, support bone regeneration. Its research-led platform is moving from proof of concept toward dental and orthopaedic products.

An AI-guided tissue-engineering platform that grows human micro-tissues and models their responses to support drug research and development.

Big Picture Bio builds a cancer research model that predicts which drug combinations may work together, helping biopharma teams prioritize therapies and experiments.

An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.

Chemify turns digital chemistry programs into real molecules through software, robotics and AI. Pharmaceutical, biotechnology and materials R&D teams can use its Chemputation platform and automated Chemifarm to design, synthesize and test compounds.

Mithrl builds a scientific decision engine for biopharma and research teams. Its biomedical world model combines validated biological knowledge with each organization’s data, then uses AI agents and workflows to help scientists analyze experiments, assess hypotheses and accelerate drug-discovery decisions; the company is preparing its next-generation platform for broader deployment.

A clinical-stage biotechnology company developing an oral drug candidate for thyroid eye disease.

Circle Pharma discovers macrocycle medicines for cancer and other serious diseases using its MXMO platform, which combines computational, structure-based design with synthetic chemistry to create cell-permeable compounds against difficult protein targets. Its lead programs are investigational and at discovery or preclinical stages.